QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Talk About A Long Movie — The 'Oppenheimer' Film Is Literally 11 Miles Long And Weighs 600 Pounds

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Filmmaker Christopher Nolan's long-awaited film "Oppenheimer," which tells the story of physicist J. Robert Oppenheimer, the man who helped develop the atomic bomb as part of the Manhattan Project in World War II, is expected to be a smash hit at the box office when it hits theaters next month.

But even though the movie is expected to have a three-hour run time, the film is raising eyebrows for a different kind of length.

According to the Associated Press, the actual IMAX film that Nolan used to shoot the saga stretches roughly 11 miles long and weighs around 600 pounds, all running through the film projector horizontally.

The movie was filmed on a combination of IMAX 65mm and Panavision 65mm, which is then projected in IMAX 70mm.

Translation for those who aren't well-versed in film: It makes for a cinematic experience that's fully immersive.

"The sharpness and the clarity and the depth of the image is unparalleled," Nolan told the outlet. "The headline, for me, is by shooting on IMAX 70mm film, you're really letting the screen disappear. You're getting a feeling of 3D without the glasses. You've got a huge screen and you're filling the peripheral vision of the audience. You're immersing them in the world of the film."

This won't be Nolan's first wartime film positioned to score big at the box office.

Nolan's 2017 film "Dunkirk," which is about the evacuation of Allied troops from the beaches of Dunkirk during WWII, raked in roughly $527 million worldwide, making it the highest-grossing film about the Second World War to date.

His 2020 film "Tenet," which tells the fictional story of a secret agent that must stop the beginning of WWIII, grossed $363.7 million worldwide.

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Should you invest $1,000 in IMAX right now?

Before you consider IMAX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IMAX wasn't on the list.

While IMAX currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
IMAX (IMAX)
3.658 of 5 stars
$17.13+0.1%N/A37.24Moderate Buy$20.57
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Search Headlines: